News

Now Available – Gallium Ga 68 Dotatate
 

Wisconsin Medical Radiopharmacy has entered into an agreement with Advanced Accelerator Applications to receive their NETSPOT® kits, which we will use for the preparation of  gallium Ga 68 dotatate drug product for PET imaging of neuroendocrine tumors. Please contact us if you are interested in gallium Ga 68 dotatate. To learn more about NETSPOT® (gallium Ga 68 dotatate), click here 

N13 - Ammonia for Cardiac PET
 

Wisconsin Medical Cyclotron is Southeast Wisconsin's only provider of the FDA approved N13-Ammonia PET drug used for Cardiac Imaging.  Please contact us to discuss availability.  To learn more about Cardiac PET, go here

Wisconsin Medical Cyclotron receives FDA approval to market the F18-FDG PET drug meeting the original filing deadline!

 

All PET drug manufacturers were required to come into 21CFR Part 212 cGMP compliance in December of 2011.  Consequently, all PET drug manufacturers were also required to register with the FDA and accordingly file a drug application to seek approval to continue to market and distribute PET drugs.  Wisconsin Medical Cyclotron is proud to announce we not only met the original drug application filing deadline (not all PET drug manufacturers did so) but we also received approval from the FDA to manufacture and sell our PET drugs.  Click here to see our listing on the FDA Orange Book site.  Our application number is 203709 for 18F-FDG and 204356 for 13N-Ammonia.

Please check back for more news!

© 2017 Wisconsin Medical Cyclotron & Radiopharmacy